U-Blot® Research Grade Anti-Human CD220/INSR Antibody (XPA.15.247.2.018)Cat. No. WA1432Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD220/INSR Antibody (XPA.15.247.2.018)Cat. No. WA1432
U-Blot® Research Grade Anti-Human CD220/INSR Antibody (IRAB-A)Cat. No. WA1431
U-Blot® Research Grade Anti-Human CD220/INSR (XOMA 358)Cat. No. WA1430
U-Blot® Research Grade Anti-Human CD220/INSR (XOMA 129)Cat. No. WA1429
U-Blot® Research Grade Anti-Human CD220/INSR (IRAB-B)Cat. No. WA1428
U-Blot® Research Grade Anti-Human CD220/INSR (AGT-182)Cat. No. WA1427
U-Blot® Research Grade Anti-Human CD22 (SM06)Cat. No. WA1426
U-Blot® Research Grade Anti-Human CD22 (M972)Cat. No. WA1425
U-Blot® Research Grade Anti-Human CD22 (M971)Cat. No. WA1424
U-Blot® Research Grade Anti-Human CD22 (JCAR018)Cat. No. WA1423
U-Blot® Research Grade Anti-Human CD22 (hRFB4)Cat. No. WA1422
U-Blot® Research Grade Anti-Human CD22 (CAT-02-106)Cat. No. WA1421